Many afib patients at highest risk of stroke are not receiving recommended oral anticoagulant therapy, according to a study in JAMA Cardiology. Read more and read the study abstract
© 2021 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder.